chr2-26693047-G-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_002246.3(KCNK3):​c.172G>A​(p.Gly58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000275 in 1,600,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000028 ( 0 hom. )

Consequence

KCNK3
NM_002246.3 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.72

Publications

0 publications found
Variant links:
Genes affected
KCNK3 (HGNC:6278): (potassium two pore domain channel subfamily K member 3) This gene encodes a member of the superfamily of potassium channel proteins that contain two pore-forming P domains. The encoded protein is an outwardly rectifying channel that is sensitive to changes in extracellular pH and is inhibited by extracellular acidification. Also referred to as an acid-sensitive potassium channel, it is activated by the anesthetics halothane and isoflurane. Although three transcripts are detected in northern blots, there is currently no sequence available to confirm transcript variants for this gene. [provided by RefSeq, Aug 2008]
KCNK3 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pulmonary hypertension, primary, 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13362369).
BS2
High AC in GnomAdExome4 at 40 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNK3NM_002246.3 linkc.172G>A p.Gly58Ser missense_variant Exon 1 of 2 ENST00000302909.4 NP_002237.1 O14649

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNK3ENST00000302909.4 linkc.172G>A p.Gly58Ser missense_variant Exon 1 of 2 1 NM_002246.3 ENSP00000306275.3 O14649
ENSG00000295291ENST00000729046.1 linkn.-10C>T upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152122
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000138
AC:
3
AN:
217686
AF XY:
0.0000165
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000314
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000276
AC:
40
AN:
1448546
Hom.:
0
Cov.:
32
AF XY:
0.0000264
AC XY:
19
AN XY:
720698
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33106
American (AMR)
AF:
0.00
AC:
0
AN:
44256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25986
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85346
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45850
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5570
European-Non Finnish (NFE)
AF:
0.0000334
AC:
37
AN:
1109334
Other (OTH)
AF:
0.0000501
AC:
3
AN:
59920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41456
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67988
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.00000841
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pulmonary hypertension, primary, 4 Uncertain:2
Jul 16, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ClinVar contains an entry for this variant (Variation ID: 474318). This missense change has been observed in individual(s) with clinical features of KCNK3-related conditions (Invitae). This variant is present in population databases (rs753384871, gnomAD 0.003%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 58 of the KCNK3 protein (p.Gly58Ser). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNK3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Oct 10, 2022
Johns Hopkins Genomics, Johns Hopkins University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This KCNK3 missense variant (rs753384871) is rare (<0.1%) in a large population dataset (gnomAD v3.1.2: 4/152122 total alleles; 0.00263%; no homozygotes). It has been reported in ClinVar (Variation ID 474318), but has not been reported in the literature, to our knowledge. Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the other predicts that it would be tolerated. The glycine residue at this position is evolutionarily conserved across many species assessed, but several species have a different amino acid at this position, including 5 species with serine. We consider the clinical significance of c.172G>A in KCNK3 to be uncertain at this time. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.57
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.70
T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.7
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
0.33
N
REVEL
Benign
0.062
Sift
Uncertain
0.019
D
Sift4G
Uncertain
0.031
D
Polyphen
0.0080
B
Vest4
0.027
MutPred
0.50
Gain of helix (P = 0.0496);
MVP
0.31
ClinPred
0.29
T
GERP RS
3.1
PromoterAI
0.010
Neutral
Varity_R
0.23
gMVP
0.80
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs753384871; hg19: chr2-26915915; API